Publications by authors named "Neal Ready"

Claim this Profile
L
LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial.
Andrew J Armstrong, Hilary Dietz, David Balli, William J Geese, Chunzhe Duan, Neal Ready

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation.
Jingxuan Zhang, Lin Lin, Jennifer H Enzor, Prekshaben H Patel, Katelyn N Steadman, Neal E Ready

J Immunother Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cytoGPNet: Enhancing clinical outcome prediction accuracy using longitudinal cytometry data in small cohort studies.
Jingxuan Zhang, Liwen Sun, Neal E Ready, Wenbo Guo, Lin Lin

Patterns (N Y)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line Treatment.
Jair Bar, Qingqing Xu, Sudeep Karve, Pooja Hingorani, Amin A Virani, Neal E Ready

Cancer Rep (Hoboken)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Associated Molecules Lead the Way to New Therapies for Small Cell Lung Cancer.
Cameron Oswalt, Neal Ready

JCO Oncol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cytoGPNet: Enhancing Clinical Outcome Prediction Accuracy Using Longitudinal Cytometry Data in Small Cohort Studies.
Jingxuan Zhang, Liwen Sun, Neal E Ready, Wenbo Guo, Lin Lin

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis.
Cameron Wood, Liliana Lyniv, James M Isaacs, Jacob M Kaufman, Eziafa I Oduah, Neal Ready

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.
Jeffrey M Clarke, George R Simon, Hirva Mamdani, Lin Gu, James E Herndon, Neal Ready

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.
Daniel Morgensztern, Neal Ready, Melissa L Johnson, Afshin Dowlati, Noura Choudhury

Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
Sanja Dacic, William Travis, Mary Redman, Anjali Saqi, Wendy A Cooper, Neal Ready

J Thorac Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.
Hong Zheng, Xiaoqing Yu, Mohammed L Ibrahim, Dana Foresman, Mengyu Xie, Neal Ready

Cancer Immunol Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
Neal E Ready, Clarisse Audigier-Valette, Jonathan W Goldman, Enriqueta Felip, Tudor-Eliade Ciuleanu

J Immunother Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817.
Luis G Paz-Ares, Tudor-Eliade Ciuleanu, Adam Pluzanski, Jong-Seok Lee, Justin F Gainor, Neal Ready

J Thorac Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Distress and Clinical Outcomes with Immuno-Oncology Agents in Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Real-World Retrospective Cohort Study.
Monica H Bodd, Susan C Locke, Steve P Wolf, Scott Antonia, Jeffrey Crawford, Neal E Ready

Lung Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study.
Quincy Chu, Natasha B Leighl, Veerle Surmont, Carla van Herpen, Anne Sibille, Neal Ready

JTO Clin Res Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges associated with the integration of immuno-oncology agents in clinical practice.
Patrice Lazure, Aparna R Parikh, Neal E Ready, Marianne J Davies, Sophie Péloquin

BMC Med Educ· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.
Jeffrey M Clarke, Lin Gu, Xiaofei F Wang, Thomas E Stinchcombe, Marvaretta M Stevenson, Neal E Ready

JTO Clin Res Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer.
Betty C Tong, Lin Gu, Xiaofei Wang, Dennis A Wigle, Joseph D Phillips, Neal E Ready

J Thorac Cardiovasc Surg· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Chester Kao, Eric Powers, Yuan Wu, Michael B Datto, Michelle F Green, Neal E Ready

Clin Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC.
Jyoti Malhotra, Petros Nikolinakos, Ticiana Leal, Jonathan Lehman, Daniel Morgensztern, Neal Ready

J Thorac Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's next for immunotherapy in locally advanced NSCLC?
Neal Edward Ready

Clin Adv Hematol Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.
Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, Neal Ready, Martin Reck

J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Hossein Borghaei, Scott Gettinger, Everett E Vokes, Laura Q M Chow, Marco Angelo Burgio, Neal Ready

J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Amplification with Crizotinib in a Case of Sinonasal Undifferentiated Carcinoma.
Hannah Robinson, Michelle Green, Gauri Radkar, Neal Ready, John Strickler

Cancer Invest· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer.
Parth A Chodavadia, Corbin D Jacobs, Frances Wang, Joseph K Salama, Chris R Kelsey, Neal E Ready

Transl Lung Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis